Skip to content
healthcare.dev

Ruconest

NDC 71274-350, c1 esterase inhibitor recombinant, injection, powder, for solution, from Pharming Healthcare Inc..

Product NDC
71274-350
Status
Listed
Labeler
Pharming Healthcare Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125495
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71274-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CONESTAT ALFA2100 U/1
Package NDCNDC-11Package
71274-350-02712740350021 VIAL, SINGLE-USE in 1 CARTON (71274-350-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (71274-350-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/66d3fecb-32a4-7781-e053-2a91aa0a83ca
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71274-350

Use it

Look up 71274-350 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71274-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71274-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.